Steady-State Plasma Concentration Profile of Transdermal Rotigotine: An Integrated Analysis of Three, Open-Label, Randomized, Phase I Multiple Dose Studies**Results of study SP630 were partially presented at the 58th Annual Meeting of the American Academy of Neurology, San Diego, California, April 1-8, 2006, and at the 9th Cong
Clinical Therapeutics, Volume 34, No. 4, Year 2012